Literature DB >> 24258614

Metformin: are potential benefits on cancer risk extended to cancer survival?

Carlo La Vecchia1, Cristina Bosetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24258614      PMCID： PMC3868416          DOI： 10.1634/theoncologist.2013-0381

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  39 in total

1.  Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

Authors:  Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-05       Impact factor: 2.890

Review 2.  AMP-activated protein kinase in metabolic control and insulin signaling.

Authors:  Mhairi C Towler; D Grahame Hardie
Journal:  Circ Res       Date:  2007-02-16       Impact factor: 17.367

3.  Relation between insulin resistance and breast cancer among Chilean women.

Authors:  Maria Luisa Garmendia; Ana Pereira; Maria Elena Alvarado; Eduardo Atalah
Journal:  Ann Epidemiol       Date:  2007-06       Impact factor: 3.797

Review 4.  AMP-activated protein kinase--the fat controller of the energy railroad.

Authors:  Gregory R Steinberg; S Lance Macaulay; Mark A Febbraio; Bruce E Kemp
Journal:  Can J Physiol Pharmacol       Date:  2006-07       Impact factor: 2.273

5.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

Review 6.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

7.  Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

Authors:  Ryan J O Dowling; Mahvash Zakikhani; I George Fantus; Michael Pollak; Nahum Sonenberg
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies.

Authors:  Paola Pisani
Journal:  Arch Physiol Biochem       Date:  2008-02       Impact factor: 4.076

Review 9.  Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.

Authors:  Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

Review 10.  LKB1-dependent signaling pathways.

Authors:  Dario R Alessi; Kei Sakamoto; Jose R Bayascas
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.